Literature DB >> 144016

Changes in plasma steroids and bone density in Klinefelter's syndrome.

D A Smith, M S Walker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 144016     DOI: 10.1007/bf02064069

Source DB:  PubMed          Journal:  Calcif Tissue Res        ISSN: 0008-0594


× No keyword cloud information.
  3 in total

1.  The accuracy and reproducibility of bone mineral measurements in vivo'. (a) The measurement of metacarpal mineralisation using an x-ray generator.

Authors:  J Shimmins; J B Anderson; D A Smith; M Aitken
Journal:  Clin Radiol       Date:  1972-01       Impact factor: 2.350

2.  Changes in metacarpal mineral content and density in normal male and female subjects with age.

Authors:  D A Smith; J B Anderson; J Shimmins; C F Speirs; E Barnett
Journal:  Clin Radiol       Date:  1969-01       Impact factor: 2.350

3.  A new technique for the measurement of metacarpal density.

Authors:  J B Anderson; J Shimmins; D A Smith
Journal:  Br J Radiol       Date:  1966-06       Impact factor: 3.039

  3 in total
  17 in total

1.  Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone.

Authors:  A Bojesen; N Birkebæk; K Kristensen; L Heickendorff; L Mosekilde; J S Christiansen; C H Gravholt
Journal:  Osteoporos Int       Date:  2010-07-24       Impact factor: 4.507

2.  Bone mass and mineral metabolism in Klinefelter's syndrome.

Authors:  G Luisetto; I Mastrogiacomo; G Bonanni; G Pozzan; S Botteon; L Tizian; P Galuppo
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

3.  Relative hyperestrogenism in Klinefelter Syndrome: results from a meta-analysis.

Authors:  Daniele Santi; Sara De Vincentis; Sara Scaltriti; Vincenzo Rochira
Journal:  Endocrine       Date:  2019-01-30       Impact factor: 3.633

4.  Loss of bone mass in patients with Klinefelter's syndrome despite sufficient testosterone replacement.

Authors:  F H Wong; K K Pun; C Wang
Journal:  Osteoporos Int       Date:  1993-01       Impact factor: 4.507

5.  Osteoporosis occurring in two patients receiving LHRH analogs for carcinoma of the prostate.

Authors:  M P Collinson; C J Tyrrel; C Hutton
Journal:  Calcif Tissue Int       Date:  1994-04       Impact factor: 4.333

6.  Effect of testosterone therapy on bone formation in an osteoporotic hypogonadal male.

Authors:  D T Baran; M A Bergfeld; S L Teitelbaum; L V Avioli
Journal:  Calcif Tissue Res       Date:  1978-12-08

Review 7.  Risks versus benefits of testosterone therapy in elderly men.

Authors:  S Basaria; A S Dobs
Journal:  Drugs Aging       Date:  1999-08       Impact factor: 3.923

Review 8.  Recent topics related to testosterone deficiency syndrome in Japan.

Authors:  Akira Tsujimura; Norio Nonomura
Journal:  Asian J Androl       Date:  2011-04-04       Impact factor: 3.285

Review 9.  Aetiologies of male osteoporosis: identification procedures.

Authors:  J P Mattei; D Arniaud; I Tonolli; H Roux
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

10.  Effects of combined androgen blockade on bone metabolism and density in men with locally advanced prostate cancer.

Authors:  M Ozgür Tan; Cenk Yilmaz; M Cemil Uygur; Burcu Duyur; Demokan Erol
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.